What does NIPTIFY analyse?
NIPTIFY determines the risk of four of the most common chromosomal diseases in the foetus:
Turner syndrome (45,X)
If desired, the gender of the foetus can also be determined.
What is NIPTIFY?
The most up-to-date method of screening for chromosomal diseases
Part of national prenatal screening programme in Estonia
High accuracy helps avoid unnecessary invasive procedures
Analysis of foetal DNA from maternal blood sample makes it safe for both the baby and the mother
Gives peace of mind to pregnant families
How to test?
The NIPTIFY test is performed from week 10 of pregnancy
A doctor, midwife or nurse takes a blood sample
The blood sample is delivered to Precision Medicine Laboratory in Tartu, Estonia
The results of the test are communicated to the doctor or midwife within ten working days at the latest
NIPTIFY results are given and explained to you by your doctor or midwife
We developed NIPTIFY so that a modern medical service would be available to pregnant women as precise and timely as possible.
Why choose NIPTIFY?
for both foetus and mother
Assesses the risk of chromosomal diseases
From 10+ weeks of pregnancy
best value for money
NIPTIFY analyzes four of the most prevalent chromosomal conditions, which combined, cover approximately 80% of all congenital chromosomal abnormalities. In addition to Down, Edwards and Patau syndrome, NIPTIFY also reports the Turner syndrome, which is an anomaly of the X-chromosome and can occur in females only. The chart below is a summary of different NIPT tests offered in Estonia and the range of chromosomal abnormalities that they test for out of all possible versions.
We are working hard to offer you the NIPT test with the best quality and price ratio!